1. Home
  2. Health
  3. Arthritis

Osteoarthritis Treatment - Surgery and Other Treatment Options

Information on surgery and other treatment options for osteoarthritis.
Hand Osteoarthritis - New EULAR Treatment Guidelines
EULAR has issued recommendations and guidelines for the treatment of hand osteoarthritis. Symptomatic hand osteoarthritis affects 20 percent of people over 55 years old.
Risedronate May Slow Joint Destruction In Knee Osteoarthritis
Risedronate brand name Actonel, a drug typically utilized to combat the effects of osteoporosis, may slow joint destruction and delay the need for joint replacement surgery in patients with knee osteoarthritis.
Doxycycline - Doxycycline May Slow Progression Of Osteoarthritis
Doxycycline may prevent progression of osteoarthritis. More studies are needed.
Electrical Stimulation Helps Knee OA
A study of the use of home-based neuromuscular electrical stimulation (NMES) for the purpose of improving quadricep strength in older adults with knee osteoarthritis has produced promising results. The report in the July 2003 Journal of Rheumatology points to NMES as a alternative when medications, exercise, and surgery are not options.
An In-Depth Report: Osteoarthritis
An in-depth report on the causes, diagnosis, treatment, and prevention of the most common form of arthritis.
Osteoarthritis Screening Quiz
Osteoarthritis is also known as "wear-and-tear" arthritis. It is typically seen as a primary disease in older people but can occur as a secondary condition in younger people. Injury, occupation, excess weight, and genetics are among the factors which cause the cartilage of a joint to wear away. Take our Osteoarthritis Screening Quiz.
Medical Management of Osteoarthrits of the Hip and Knee
Medical management of hip or knee OA includes nonpharmacologic modalities and drug therapy, from ACR.

Explore Arthritis

More from About.com

  1. Home
  2. Health
  3. Arthritis
  4. Types of Arthritis
  5. Osteoarthritis
  6. Osteoarthritis: Treatment

©2008 About.com, a part of The New York Times Company.

All rights reserved.